Adequate levels of adherence with controller medication is associated with increased use of rescue medication in asthmatic children

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Elkout, Hajer ^a   Helms, Peter J ^a   Simpson, Colin R ^a,b   McLay, James S ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE CONTROL; DRUG MONITORING; FEMALE; HUMAN; INFANT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICATION POSSESSION RATIO; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PRESCHOOL CHILD; PRESCRIPTION; PRIMARY MEDICAL CARE; RETROSPECTIVE STUDY; SCHOOL CHILD; SEX RATIO; SOCIOECONOMICS; TREATMENT DURATION; TREATMENT RESPONSE;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ADOLESCENT; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; CHILD, PRESCHOOL; DRUG COMBINATIONS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MEDICATION ADHERENCE; OUTCOME ASSESSMENT (HEALTH CARE); PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES;

EID: 84862977108     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039130     Document Type: Article

References (34)

1. Straand J, Rokstad K, Heggedal U, (1998) Drug prescribing for children in general practice. A report from More & Romsdal Prescription Study. Acta Paediatr 87: 218-24.
2. The Scottish Government. 2010. The Scottish Health Survey - Results Available from:http://www.scotland.gov.uk/Publications/2011/09/27084018/58 (Accessed on 10.04.2012).
3. Laforest L, Pacheco Y, Bousquet J, Yin D, van Ganse E, (2004) How appropriate is asthma therapy in general practice? Fundam Clin Pharmacol 19(1): 107-115.
4. Anis AH, Lynd LD, Wang X, King G, Spinelli JJ, et al. (2001) Double trouble: impact of inappropriate use of asthma medication on the use of health care resources. Can Med Assoc J 164: 625-31.
5. Milgrom H, Bender B, Ackerson L, Bowry P, Smith B, et al. (1996) Noncompliance and treatment failure inchildren with asthma. J Allergy Clin lmmunol 98: 1051-1057.
6. Camargo CA, Ramachandran S, Ryskina KL, Lewis BE, Legorreta AP, (2007) Association between common asthma therapies and recurrent asthma exacerbations in children enrolled in a state Medicaid plan. Am J Health-Syst Ph 64(10): 1054-1061.
7. Mattke S, Martorell F, Hong SY, Sharma P, Cuellar A, et al. (2010) Anti-inflammatory medication adherence and cost and utilization of asthma care in a commercially insured population. J Asthma 47(3): 323-329.
8. Cochrane MG, Bala MV, Downs KE, Mauskopf J, Ben-Joseph RH, (2000) Inhaled Corticosteroids for Asthma Therapy: Patient Compliance, Devices, and Inhalation Technique. Chest 117(2): 542-550.
9. Horne R, (2006) Compliance, Adherence, and Concordance. Chest 130(1 suppl).
10. Bender B, Zhang L, (2008) Negative effect, medication adherence, and asthma control in children. J Allergy Clin lmmunol 122(3): 490-495.
11. Lasmar L, Camargos P, Bousquet J, Goulart E, Sakurai E, et al. (2009) Factors related to lower adherence rates to inhaled corticosteroids in children and adolescents: a prospective randomized cohort study. J Trop Pediatrics 55(1): 20.
12. Broder MS, Chang EY, Kamath T, Sapra S, (2010) Poor disease control among insured users of high-dose combination therapy for asthma, Allergy Asthma Proc 31: 60-67.
13. ISD Scotland, General practice-Practice Team Information database, PTI. Available from:http://www.isdscotlandarchive.scot.nhs.uk/isd/3727.html (accessed on 04/04/2011).
14. Haupt D, Nilsson JLG, (2009) Asthma medication - persistence with adrenergics, steroids and combination products over a 5-year period. J Clin Pharm Ther 34: 507-513.
15. Krigsman K, Nilsson JLG, Ring L, (2007) Refill adherence for patients with asthma and COPD: comparison of a pharmacy record database with manually collected repeat prescriptions. Pharmacoepidemiol Drug Saf 16(4): 441-448.
16. Delea TE, Hagiwara M, Stanford RH, Stempel DA, (2008) Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma. Clin Ther 30: 560-71.
17. Stoloff SW, Stempel DA, Meyer J, Stanford RH, Carranza Rosenzweig JR, (2004) Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies. J Allergy Clin Immunol 113: 245-51.
18. Bukstein DA, Henk HJ, Luskin AT, (2001) A comparison of asthma related expenditures for patients started on montelukast versus fluticasone propionate as monotherapy. Clin therap 23(9): 1589-1600.
19. Guénette L, Moisan J, Préville M, Boyer R, (2005) Measures of adherence based on self-report exhibited poor agreement with those based on pharmacy records. J Clin Epidemiol 58(9): 924-933.
20. Hudson M, Rahme E, Richard H, Pilote L, (2007) Comparison of measures of medication persistency using a prescription drug database. Am Heart J 153(1): 59-65.
21. Williams LK, Joseph CL, Peterson EL, Wells K, Wang M, et al. (2007) Patients with asthma who do not fill their inhaled corticosteroids: a study of primary nonadherence. J Allergy Clin lmmunol 120: 1153-9.
22. Balkrishnan R, Nelsen LM, Kulkarni AS, Pleasants RA, Whitmire JT, et al. (2005) Outcomes associated with initiation of different controller therapies in a Medicaid asthmatic population: a retrospective data analysis. J Asthma 42 (1): 35-40.
23. Stempel D, Stoloff S, Carranza Rosenzweig J, Stanford R, Ryskina K, et al. (2005) Adherence to asthma controller medication regimens. Respir Med 99(10): 1263-1267.
24. Jones C, Santanello NC, Boccuzzi SJ, Wogen J, Strub P, et al. (2003) Adherence to prescribed treatment for asthma: evidence from pharmacy benefits data. J Asthma 40(1): 93-101.
25. Latry P, Pinet P, Labat A, Jean-Pierre M, Claude P, et al. (2008) Adherence to Anti-inflammatory treatment for asthma in clinical practice in France. Clin Therap 30: 1058-1068.
26. Rosenhall L, Elvstrand A, Tilling B, Vinge I, Jemsby P, et al. (2003) One-year safety and efficacy of budesonide/formoterol in a single inhaler (Symbicorto Turbuhalero) for the treatment of asthma. Respir Med 97(6): 702-708.
27. Bender BG, Pedan A, Varasteh LT, (2006) Adherence and persistence with fluticasone propionate/salmeterol combination therapy. J Allergy Clin lmmunol 118(4): 899-904.
28. Chan J, Hui R, Spence M, (2007) Effects on Resource Utilization of Adding Salmeterol in Combination or Separately to Inhaled Corticosteroids. J Manag Care Pharm 13(1): 21-27.
29. Butz AM, Tsoukleris M, Donithan M, Doren V, Mudd K, et al. (2006) Patterns of inhaled anti-inflammatory medication use in young underserved children with asthma. Pediatrics 118(6): 2504-2413.
30. Osman L, Friend J, Legge J, Douglas J, (1999) Requests for repeat medication prescriptions and frequency of acute episodes in asthma patients. J Asthma 36(5): 449-457.
31. Walders N, Kopel SJ, Koinis-Mitchell D, McQuaid EL, (2005) Patterns of quick-relief and long-term controller medication use in pediatric asthma. J pediatrics 146(2): 177-182.
32. Ferrell CW, Aspy CB, Mold JW, (2006) Management of prescription refills in primary care: an Oklahoma physicians resource/research network (OKPRN) study. J Am Board Fam Med 19(1): 31-38.
33. Riekert KA, Butz AM, Eggleston PA, Huss K, Winkelstein M, et al. (2003) Caregiver-physician medication concordance and undertreatment of asthma among inner-city children. Pediatrics 111(3): e214-220.
34. Smyth A, Barbato A, Beydon N, Bisgaard H, de Boeck K, et al. (2010) Respiratory medicines for children: current evidence, unlicensed use and research priorities. European Respiratory Journal 35(2): 247-265.